# Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients

> **NCT05001074** · PHASE3 · UNKNOWN · sponsor: **Heleen Grootjans** · enrollment: 145 (estimated)

## Conditions studied

- Lung Transplant; Complications

## Interventions

- **DRUG:** Extended release tacrolimus
- **DRUG:** Immediate release tacrolimus

## Key facts

- **NCT ID:** NCT05001074
- **Lead sponsor:** Heleen Grootjans
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-28
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2023-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05001074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05001074, "Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05001074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
